In the last 12 months, insiders at PharmaCyte Biotech, Inc. ($PMCB) filed 28 transactions with the SEC: 6 open-market purchases totaling $128,708 and 0 sales totaling $0. Net insider sentiment: net buying.
PharmaCyte Biotech, Inc. operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- Silverman Joshua (CEO and President) — 5 transactions totaling $344,401
- SCHECHTER JONATHAN (Director) — 8 transactions totaling $117,082
- WEINSTEIN ROBERT (Director) — 5 transactions totaling $34,425
- WALKER WAYNE REMELL (Director) — 5 transactions totaling $17,213
- Abecassis Michael M (Director) — 5 transactions totaling $17,213
View all SEC Filings for PharmaCyte Biotech, Inc. (PMCB).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | WEINSTEIN ROBERT | Director | A | Stock Option (Right to Buy) | 119170 | $0.00 | 119,170.0000 | 10,134,160 | 9999.99% | 1.18% |
| March 31, 2026 | SCHECHTER JONATHAN | Director | A | Stock Option (Right to Buy) | 119170 | $0.00 | 119,170.0000 | 10,134,160 | 9999.99% | 1.18% |
| March 31, 2026 | WALKER WAYNE REMELL | Director | A | Stock Option (Right to Buy) | 119170 | $0.00 | 119,170.0000 | 10,134,160 | 9999.99% | 1.18% |
| March 31, 2026 | Abecassis Michael M | Director | A | Stock Option (Right to Buy) | 119170 | $0.00 | 119,170.0000 | 10,134,160 | 9999.99% | 1.18% |
| Jan. 5, 2026 | Silverman Joshua | CEO and President | P | Common Stock | 30000 | $0.78 | 396,250.0000 | 10,134,160 | 8.19% | 0.30% |
| Jan. 6, 2026 | Silverman Joshua | CEO and President | P | Common Stock | 30000 | $0.79 | 426,250.0000 | 10,134,160 | 7.57% | 0.30% |
| Jan. 7, 2026 | Silverman Joshua | CEO and President | P | Common Stock | 40000 | $0.83 | 466,250.0000 | 10,134,160 | 9.38% | 0.39% |
| Jan. 5, 2026 | SCHECHTER JONATHAN | Director | P | Common Stock | 20000 | $0.78 | 152,500.0000 | 10,134,160 | 15.09% | 0.20% |
| Jan. 6, 2026 | SCHECHTER JONATHAN | Director | P | Common Stock | 20000 | $0.79 | 172,500.0000 | 10,134,160 | 13.11% | 0.20% |
| Jan. 7, 2026 | SCHECHTER JONATHAN | Director | P | Common Stock | 20000 | $0.84 | 192,500.0000 | 10,134,160 | 11.59% | 0.20% |
| Dec. 12, 2025 | SCHECHTER JONATHAN | Director | F | Common Stock | 67500 | $1.02 | 132,500.0000 | 6,795,779 | 33.75% | 0.99% |
| Dec. 12, 2025 | Abecassis Michael M | Director | A | Common Stock | 37500 | $0.00 | 39,967.0000 | 6,795,779 | 1520.07% | 0.55% |
| Dec. 12, 2025 | Abecassis Michael M | Director | F | Common Stock | 16875 | $1.02 | 23,092.0000 | 6,795,779 | 42.22% | 0.25% |
| April 25, 2025 | Abecassis Michael M | Director | A | Stock Option (Right to Buy) | 63233 | $0.00 | 63,233.0000 | 0 | 9999.99% | 0.00% |
| April 25, 2025 | SCHECHTER JONATHAN | Director | A | Stock Option (Right to Buy) | 63233 | $0.00 | 63,233.0000 | 0 | 9999.99% | 0.00% |
| Dec. 12, 2025 | WEINSTEIN ROBERT | Director | A | Common Stock | 75000 | $0.00 | 75,000.0000 | 6,795,779 | 9999.99% | 1.10% |
| Dec. 12, 2025 | WEINSTEIN ROBERT | Director | F | Common Stock | 33750 | $1.02 | 41,250.0000 | 6,795,779 | 45.00% | 0.50% |
| April 25, 2025 | WEINSTEIN ROBERT | Director | A | Stock Option (Right to Buy) | 63233 | $0.00 | 63,233.0000 | 0 | 9999.99% | 0.00% |
| Dec. 12, 2025 | WALKER WAYNE REMELL | Director | A | Common Stock | 37500 | $0.00 | 37,500.0000 | 6,795,779 | 9999.99% | 0.55% |
| Dec. 12, 2025 | WALKER WAYNE REMELL | Director | F | Common Stock | 16875 | $1.02 | 20,625.0000 | 6,795,779 | 45.00% | 0.25% |
| April 25, 2025 | WALKER WAYNE REMELL | Director | A | Stock Option (Right to Buy) | 63233 | $0.00 | 63,233.0000 | 0 | 9999.99% | 0.00% |
| Dec. 12, 2025 | Silverman Joshua | CEO and President | A | Common Stock | 575000 | $0.00 | 625,000.0000 | 6,795,779 | 1150.00% | 8.46% |
| Dec. 12, 2025 | Silverman Joshua | CEO and President | F | Common Stock | 258750 | $1.02 | 366,250.0000 | 6,795,779 | 41.40% | 3.81% |
| Dec. 12, 2025 | SCHECHTER JONATHAN | Director | A | Common Stock | 150000 | $0.00 | 200,000.0000 | 6,795,779 | 300.00% | 2.21% |
| April 30, 2024 | WEINSTEIN ROBERT | Director | A | Stock Option (Right to Buy) | 38009 | $0.00 | 38,009.0000 | 0 | 9999.99% | 0.00% |
| April 30, 2024 | Abecassis Michael M | Director | A | Stock Option (Right to Buy) | 38009 | $0.00 | 38,009.0000 | 0 | 9999.99% | 0.00% |
| April 30, 2024 | SCHECHTER JONATHAN | Director | A | Stock Option (Right to Buy) | 38009 | $0.00 | 38,009.0000 | 0 | 9999.99% | 0.00% |
| April 30, 2024 | WALKER WAYNE REMELL | Director | A | Stock Option (Right to Buy) | 38009 | $0.00 | 38,009.0000 | 0 | 9999.99% | 0.00% |